Tasly Pharma Subsidiary Obtains SFDA Approval For Subunit Flu Vaccine
This article was originally published in PharmAsia News
Executive Summary
Tasly Pharmaceutical subsidiary Jinna Biotech announced that it recently received SFDA approval for its influenza subunit vaccine May 7